BENEMID Drug Patent Profile
✉ Email this page to a colleague
When do Benemid patents expire, and what generic alternatives are available?
Benemid is a drug marketed by Merck and is included in one NDA.
The generic ingredient in BENEMID is probenecid. There are ten drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the probenecid profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Benemid
A generic version of BENEMID was approved as probenecid by WATSON LABS TEVA on March 29th, 1983.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BENEMID?
- What are the global sales for BENEMID?
- What is Average Wholesale Price for BENEMID?
Summary for BENEMID
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 117 |
| Clinical Trials: | 2 |
| Patent Applications: | 2,512 |
| DailyMed Link: | BENEMID at DailyMed |
Recent Clinical Trials for BENEMID
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Calgary | Phase 2/Phase 3 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
US Patents and Regulatory Information for BENEMID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Merck | BENEMID | probenecid | TABLET;ORAL | 007898-004 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
